PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11891774-4	2002	STI571, an Abl family kinase inhibitor, further accentuates these stimulatory effects.	Imatinib Mesylate	0-6	ABL proto-oncogene 1, non-receptor tyrosine kinase	Rattus norvegicus	11-14	
23300967-2	2013	In this paper we report that Gleevec (Imatinib), an Abl family kinase inhibitor, produces a profound change in the shape and migration of rat bladder tumor cells (NBTII) plated on collagen-coated substrates.	Imatinib Mesylate	29-36	ABL proto-oncogene 1, non-receptor tyrosine kinase	Rattus norvegicus	52-55	
23300967-2	2013	In this paper we report that Gleevec (Imatinib), an Abl family kinase inhibitor, produces a profound change in the shape and migration of rat bladder tumor cells (NBTII) plated on collagen-coated substrates.	Imatinib Mesylate	38-46	ABL proto-oncogene 1, non-receptor tyrosine kinase	Rattus norvegicus	52-55	
22447116-1	2012	FB2 is a promising Abl/Src dual tyrosine kinase inhibitor which is designed to overcome imatinib resistance.	Imatinib Mesylate	88-96	ABL proto-oncogene 1, non-receptor tyrosine kinase	Rattus norvegicus	19-22	
12543778-5	2003	Addition of the Abl kinase inhibitor STI-571 to ABL SH2-transformed Rat-1 cells inhibited tyrosine phosphorylation of p145 ABL.	Imatinib Mesylate	37-44	ABL proto-oncogene 1, non-receptor tyrosine kinase	Rattus norvegicus	48-51